Who owns Seres Therapeutics?
- CUSIP Number: 81750r102
Tip: Access positions for across all investors
Analyze quarterly positions in Seres Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seres Therapeutics stock
Who bought or sold Seres Therapeutics this quarter?
There are no current stakeholders of Seres Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Seres Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2025 | 75k | $52k |
| H D Vest Advisory Services | Mar 2025 | 45k | $32k |
| Jpmorgan Chase & Co | Mar 2025 | 1.3k | $913.060800 |